Photofrin is a medication used for photodynamic therapy in the treatment of various conditions, including esophageal cancer, obstructing endobronchial cancer, superficial endobronchial tumors, and high-grade dysplasia in Barrett's Esophagus. It is important to note that Photofrin should not be taken by individuals with certain medical conditions, such as porphyria or abnormal connections between the esophagus and airways. Patients receiving Photofrin treatment should take precautions to avoid exposure to direct sunlight or bright indoor light for at least 30 days, as the medication can cause phototoxicity reactions.
Common side effects of Photofrin include sensitivity to light, allergic reactions, anemia, accumulation of fluid in the lungs, constipation, nausea, chest pain, difficulty breathing, and vomiting. It is also important to inform healthcare providers about any other medications being taken, as some may be activated by light and interact with Photofrin. Patients with liver or kidney problems may require extra precautions regarding light sensitivity. Overall, Photofrin is a medication that should be used under the guidance of a healthcare professional and with careful consideration of the potential risks and benefits.
Generated from the website